Skip to main content
. 2019 Dec 17;10(6):e02591-19. doi: 10.1128/mBio.02591-19

FIG 2.

FIG 2

Tryptophan metabolites reactivate HIV-1 in cells isolated from cART-treated patients. (A) PBMCs isolated from cART-treated HIV-1 patients were treated with Kyn (200 μM) or FICZ (500 nM) for 4 days. TNF-α (1 μg/ml) stimulation was used as a positive control. (B) Purified resting CD4+ T cells from cART-treated HIV-1 patients were stimulated with FICZ (10 μM) for 4 days. Viral reactivation was measured by quantifying the production of intracellular gag mRNA for donors 1 to 3 (A) and donors 4 to 7 (B). The fold enrichment representing viral reactivation relative to medium treatment was calculated.